KeyCorp reaffirmed their buy rating on shares of athenahealth (NASDAQ:ATHN) in a report issued on Friday. They currently have a $152.00 price target on the health services provider’s stock.

ATHN has been the subject of a number of other research reports. Cantor Fitzgerald reiterated a hold rating and set a $120.00 price target on shares of athenahealth in a research report on Friday, October 27th. BidaskClub upgraded athenahealth from a strong sell rating to a sell rating in a research report on Saturday, December 2nd. Deutsche Bank started coverage on athenahealth in a research report on Friday, December 8th. They set a hold rating and a $145.00 price target for the company. Leerink Swann reduced their price target on athenahealth from $155.00 to $125.00 and set a market perform rating for the company in a research report on Monday, October 23rd. Finally, Royal Bank of Canada set a $144.00 price target on athenahealth and gave the stock a hold rating in a research report on Friday, October 20th. One research analyst has rated the stock with a sell rating, seventeen have assigned a hold rating and nine have issued a buy rating to the company. The company currently has a consensus rating of Hold and an average price target of $143.96.

Shares of athenahealth (ATHN) traded down $1.67 during mid-day trading on Friday, reaching $127.80. The company’s stock had a trading volume of 195,371 shares, compared to its average volume of 365,211. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth has a one year low of $95.01 and a one year high of $158.66. The firm has a market cap of $5,180.00, a price-to-earnings ratio of 165.97, a PEG ratio of 3.03 and a beta of 1.58.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company had revenue of $304.60 million during the quarter, compared to analyst estimates of $310.52 million. During the same quarter in the previous year, the firm posted $0.60 EPS. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. analysts predict that athenahealth will post 1.22 EPS for the current year.

In other news, CEO Jonathan Bush sold 30,000 shares of the business’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $134.80, for a total transaction of $4,044,000.00. Following the sale, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at $43,244,783.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction on Friday, October 20th. The stock was sold at an average price of $130.00, for a total value of $104,000.00. The disclosure for this sale can be found here. Insiders have sold 69,700 shares of company stock worth $9,375,172 over the last ninety days. 3.20% of the stock is owned by insiders.

Several institutional investors have recently made changes to their positions in ATHN. Schwab Charles Investment Management Inc. raised its position in shares of athenahealth by 6.2% during the second quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock worth $24,031,000 after purchasing an additional 9,960 shares during the period. First Trust Advisors LP acquired a new stake in shares of athenahealth during the second quarter worth $219,000. Legal & General Group Plc raised its position in shares of athenahealth by 11.2% during the second quarter. Legal & General Group Plc now owns 14,358 shares of the health services provider’s stock worth $2,018,000 after purchasing an additional 1,444 shares during the period. BNP Paribas Arbitrage SA grew its holdings in shares of athenahealth by 123.8% during the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after buying an additional 744 shares in the last quarter. Finally, Prudential Financial Inc. grew its holdings in shares of athenahealth by 4.9% during the second quarter. Prudential Financial Inc. now owns 2,146 shares of the health services provider’s stock valued at $302,000 after buying an additional 100 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/01/16/athenahealth-athn-earns-buy-rating-from-keycorp.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related stocks with our FREE daily email newsletter.